| | | | | | | | | | | | | | | | | | | | | |
<?xml version="1.0" standalone="no" encoding="windows-1252"?> |
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3c --> |
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co --> |
<!-- Field: Doc-Info; Name: Source; Value: BLNC %2D 20200331 10Q Q1 DFN.xfr; Date: 2020%2D07%2D06T17:44:04Z --> |
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> |
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> |
| <link:roleRef roleURI="http://balancelabs.co/role/DocumentAndEntityInformation" xlink:href="blnc-20200331.xsd#DocumentAndEntityInformation" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/BalanceSheets" xlink:href="blnc-20200331.xsd#BalanceSheets" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/BalanceSheetsParenthetical" xlink:href="blnc-20200331.xsd#BalanceSheetsParenthetical" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/StatementOfOperations" xlink:href="blnc-20200331.xsd#StatementOfOperations" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/StatementOfChangesInStockholdersDeficit" xlink:href="blnc-20200331.xsd#StatementOfChangesInStockholdersDeficit" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/StatementOfCashFlows" xlink:href="blnc-20200331.xsd#StatementOfCashFlows" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/BusinessOrganizationAndNatureOfOperations" xlink:href="blnc-20200331.xsd#BusinessOrganizationAndNatureOfOperations" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/GoingConcern" xlink:href="blnc-20200331.xsd#GoingConcern" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/StockholdersEquity" xlink:href="blnc-20200331.xsd#StockholdersEquity" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/RelatedPartyTransactions" xlink:href="blnc-20200331.xsd#RelatedPartyTransactions" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/CommitmentsAndContingencies" xlink:href="blnc-20200331.xsd#CommitmentsAndContingencies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/NotesPayable" xlink:href="blnc-20200331.xsd#NotesPayable" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SubsequentTransactions" xlink:href="blnc-20200331.xsd#SubsequentTransactions" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/StockholdersEquityTables" xlink:href="blnc-20200331.xsd#StockholdersEquityTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/GoingConcernDetailsNarrative" xlink:href="blnc-20200331.xsd#GoingConcernDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetailsParenthetical" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetailsParenthetical" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfJoinVentureOfFinancialInformationDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfJoinVentureOfFinancialInformationDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueOfAssetsOnRecurringBasisDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueOfAssetsOnRecurringBasisDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfReconciliationOfAssetsDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfReconciliationOfAssetsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPropertyAndEquipmentDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfIntangibleAssetsDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfIntangibleAssetsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/StockholdersEquityDetailsNarrative" xlink:href="blnc-20200331.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/StockholdersEquity-SummaryOfWarrantsOutstandingDetails" xlink:href="blnc-20200331.xsd#StockholdersEquity-SummaryOfWarrantsOutstandingDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="blnc-20200331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="blnc-20200331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/NotesPayableDetailsNarrative" xlink:href="blnc-20200331.xsd#NotesPayableDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://balancelabs.co/role/SubsequentTransactionsDetailsNarrative" xlink:href="blnc-20200331.xsd#SubsequentTransactionsDetailsNarrative" xlink:type="simple"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets"> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesNoncurrent" xlink:label="loc_us-gaapDueFromRelatedPartiesNoncurrent"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDueFromRelatedPartiesNoncurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="loc_us-gaapInvestmentOwnedAtFairValue"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapInvestmentOwnedAtFairValue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill"/> |
| | <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="blnc-20200331.xsd#BLNC_ConvertibleNotesPayableRelatedPartyCurrent" xlink:label="loc_BLNCConvertibleNotesPayableRelatedPartyCurrent"/> |
| | <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_BLNCConvertibleNotesPayableRelatedPartyCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent"/> |
| | <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent"/> |
| | <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="blnc-20200331.xsd#BLNC_AccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment" xlink:label="loc_BLNCAccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment"/> |
| | <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_BLNCAccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesNoncurrent"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDueToRelatedPartiesNoncurrent" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDueToRelatedPartiesNoncurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StatementOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statement of Operations (Unaudited)"> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:label="loc_us-gaapRelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapRelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSalariesAndWages" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleUnrealizedGainLoss"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StatementOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Deficit (Unaudited)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StatementOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited)"> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="blnc-20200331.xsd#BLNC_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss1" xlink:label="loc_BLNCEquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss1"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_BLNCEquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss1" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/> |
| | <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedParties"/> |
| | <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments"/> |
| | <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaapPaymentsToAcquireEquityMethodInvestments"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/BusinessOrganizationAndNatureOfOperations" xlink:title="00000007 - Disclosure - Business Organization and Nature of Operations"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/GoingConcern" xlink:title="00000008 - Disclosure - Going Concern"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StockholdersEquity" xlink:title="00000010 - Disclosure - Stockholders' Equity"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/RelatedPartyTransactions" xlink:title="00000011 - Disclosure - Related Party Transactions"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/CommitmentsAndContingencies" xlink:title="00000012 - Disclosure - Commitments and Contingencies"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/NotesPayable" xlink:title="00000013 - Disclosure - Notes Payable"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SubsequentTransactions" xlink:title="00000014 - Disclosure - Subsequent Transactions"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000015 - Disclosure - Summary of Significant Accounting Policies (Policies)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000016 - Disclosure - Summary of Significant Accounting Policies (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StockholdersEquityTables" xlink:title="00000017 - Disclosure - Stockholders' Equity (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/GoingConcernDetailsNarrative" xlink:title="00000018 - Disclosure - Going Concern (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000019 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetails" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies - Schedule of Equity Method Investments (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetailsParenthetical" xlink:title="00000021 - Disclosure - Summary of Significant Accounting Policies - Schedule of Equity Method Investments (Details) (Parenthetical)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfJoinVentureOfFinancialInformationDetails" xlink:title="00000022 - Disclosure - Summary of Significant Accounting Policies - Schedule of Join Venture of Financial Information (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueOfAssetsOnRecurringBasisDetails" xlink:title="00000023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value of Assets on Recurring Basis (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfReconciliationOfAssetsDetails" xlink:title="00000024 - Disclosure - Summary of Significant Accounting Policies - Schedule of Reconciliation of Assets (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000025 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)"> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfIntangibleAssetsDetails" xlink:title="00000026 - Disclosure - Summary of Significant Accounting Policies - Schedule of Intangible Assets (Details)"> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet"/> |
| | <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedTrademarksGross" xlink:label="loc_us-gaapFiniteLivedTrademarksGross"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedTrademarksGross" xlink:type="arc" weight="1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StockholdersEquityDetailsNarrative" xlink:title="00000027 - Disclosure - Stockholders' Equity (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StockholdersEquity-SummaryOfWarrantsOutstandingDetails" xlink:title="00000028 - Disclosure - Stockholders' Equity - Summary of Warrants Outstanding (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000029 - Disclosure - Related Party Transactions (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000030 - Disclosure - Commitments and Contingencies (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/NotesPayableDetailsNarrative" xlink:title="00000031 - Disclosure - Notes Payable (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SubsequentTransactionsDetailsNarrative" xlink:title="00000032 - Disclosure - Subsequent Transactions (Details Narrative)"/> |
| </link:linkbase> |